Marella Thorell - 01 Jul 2022 Form 4 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role
Director
Signature
/s/ David Baker, attorney-in-fact
Issuer symbol
GRI
Transactions as of
01 Jul 2022
Net transactions value
$0
Form type
4
Filing time
06 Jul 2022, 14:03:57 UTC
Previous filing
01 Nov 2022
Next filing
18 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRI Common Stock Award $0 +38,023 $0.000000 38,023 01 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of restricted stock units (RSUs). The RSUs vest in four (4) equal quarterly installments such that the RSU will be fully vested on the first (1st) anniversary of the date of grant, subject to continued service with the Issuer. Each RSU represents the right to receive one share of common stock of Vallon Pharmaceuticals, Inc.